JA Schalken

Models for studying benign prostatic hyperplasia

Wanna Mahapokai, FJ van Sluijs, JA Schalken · Prostate Cancer and Prostatic Diseases · 2000 · 67 citations

Medicine, Endocrinology, Urology +10

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

Yahya Tamimi, HG van der Poel, HFM Karthaus et al. · British Journal of Cancer · 1996 · 62 citations · Full text

Medicine, Oncology, Urology +15

p16 mutations/deletions are not frequent events in prostate cancer

Yahya Tamimi, P P Bringuier, Frank Smit et al. · British Journal of Cancer · 1996 · 47 citations · Full text

Medicine, Molecular Genetics, Oncology +10

Analysis of expression of chorionic gonadotrophin transcripts in prostate cancer by quantitative Taqman and a modified molecular beacon RT-PCR

CM Thomas, J.J.M. van den Heuvel, RR Bosch et al. · Journal of Endocrinology · 2002 · 20 citations · Full text

Medicine, Endocrinology, Oncology +11

A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia

MR Feneley, JA Schalken, M. E. Harper et al. · Prostate Cancer and Prostatic Diseases · 1999 · 17 citations

Medicine, Pharmacotherapy, Urology +12